133486-01-8

Usage

Uses

Used in Pharmaceutical Research:
4-[2-BUTYL-5-(2-METHOXYCARBONYL-3-THIOPHEN-2-YL-PROPENYL)-IMIDAZOL-1-YLMETHYL]-BENZOIC ACID is used as a research compound for exploring its potential pharmacological activities. Its unique structure suggests that it may have applications in the development of new drugs targeting various therapeutic areas.
Used in Drug Development:
In the pharmaceutical industry, 4-[2-BUTYL-5-(2-METHOXYCARBONYL-3-THIOPHEN-2-YL-PROPENYL)-IMIDAZOL-1-YLMETHYL]-BENZOIC ACID is used as a lead compound in the discovery and optimization of new therapeutic agents. Its imidazole and benzoic acid derivatives may offer a foundation for creating molecules with specific biological activities, making it a valuable asset in the drug development pipeline.
Used in Medicinal Chemistry:
4-[2-BUTYL-5-(2-METHOXYCARBONYL-3-THIOPHEN-2-YL-PROPENYL)-IMIDAZOL-1-YLMETHYL]-BENZOIC ACID serves as a key component in medicinal chemistry, where it is utilized to understand the structure-activity relationships of related compounds. This knowledge can be applied to design and synthesize novel molecules with improved pharmacological profiles for various medical applications.

Upstream product

• 135123-85-2 4-[5-((E)-2-tert-Butoxycarbonyl-3-thiophen-2-yl-propenyl)-2-butyl-imidazol-1-ylmethyl]-benzoic acid methyl ester 
• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 138150-17-1 (E)-3-Thiophen-2-yl-acrylic acid tert-butyl ester 
• 133486-67-6 tert-butyl 3-(thiophen-2-yl)propanoate 
• 133040-02-5 2-butyl-4-chloro-1-<(4-carbomethoxyphenyl)methyl>-1H-imidazole-5-carboxaldehyde 
• 133040-03-6 2-n-butyl-1-[(4-carbomethoxyphenyl)methyl]-1H-imidazol-5-carboxaldehyde 
• 83857-96-9 2-n-butyl-4-chloro-1H-imidazol-5-carboxaldehyde 
• 98-03-3 thiophene-2-carbaldehyde 

Downstream Products

• 148674-53-7 4-[2-Butyl-5-((E)-2-cyano-3-thiophen-2-yl-propenyl)-imidazol-1-ylmethyl]-benzoic acid methyl ester 
• 148674-45-7 (E)-3-<2-butyl-1-<(4-carbomethoxyphenyl)methyl>imidazol-5-yl>-2-(2-thienylmethyl)-2-propenamide 

Relevant academic research and scientific papers

Potent Nonpeptide Angiotensin II Receptor Antagonists. 2. (1-Carboxybenzyl)imidazole-5-acrylic Acids

The further evolution of the imidazole-5-acrylic acid series of nonpeptide angiotensin II receptor antagonists is detailed (for Part 1, see: J.Med.Chem. 1992, 35, 3858).Modifications of the N-benzyl ring substitution were undertaken in an effort to mimic the Tyr4 residue of angiotensin II.Introduction of a p-carboxylic acid on the N-benzyl ring resulted in the discovery of compounds with nanomolar affinity for the receptor and good oral activity.SAR studies of these potent antagonists revealed that the thienyl ring, the (E)-acrylic acid, and the imidazole ring in addition to the two acid groups were important for high potency.Also, overlay comparisons of the parent diacid with both angiotensin II and a representative biphenylyltetrazole nonpeptide angiotensin II receptor antagonist are presented.The parent diacid analog, SKF 108566 or (E)-3--2-propenoic acid, is currently in clinical development for the treatment of hypertension.

Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists

Angiotensin II receptor antagonists having the formula: STR1 which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.